Rolling Stone reports that CDC director's office staff instructed the agency's budget office in late September to earmark $1.6 million for a vaccine trial in Guinea-Bissau that was suspended in January after being widely criticized as unethical. The trial, which would expose newborns to hepatitis B risk, is to be run by Danish researchers Christine Stabell Benn and Peter Aaby, who are currently under investigation by Danish authorities for alleged scientific misconduct. HHS did not respond to a request for comment.
arstechnica.com
· 2026-10-09
Researchers have built a biodegradable battery using magnesium and molybdenum trioxide electrodes with an edible ionic-liquid electrolyte, designed to power ingestible medical devices. The battery, described in Nature Chemical Engineering, has been tested successfully in pigs and breaks down into absorbable materials after use.
nature.com
· 2026-09-22
Researchers at nChroma Bio and Milan-based institutes developed a therapy that attaches chemical tags to the hepatitis B virus genome, silencing its genes without cutting DNA. Tests in human liver cells and mice showed the approach effectively blocked viral particle production, and monkey trials revealed only mild, short-lived side effects after a single dose. A human clinical trial has since begun in Hong Kong and New Zealand, with the first patient dosed in January.
nature.com
· 2026-09-21